Comparative performances of enzyme-linked immunosorbent, Western blot, and polymerase chain reaction assays for human T-lymphotropic virus type II infection that is endemic among Indians of the Gran Chaco region of South America

被引:10
作者
Poiesz, BJ
Dube, S
Jones, B
BryzGornia, V
Dean, MT
Spicer, T
Hengst, J
Sayre, K
Esteban, E
Ferrer, JF
机构
[1] CELLULAR PROD, BUFFALO, NY USA
[2] ORTHO DIAGNOST SYST INC, RARITAN, NJ USA
[3] UNIC NACL CTR PROV, FAC CIENCIAS VET, BUENOS AIRES, DF, ARGENTINA
[4] UNIV PENN, NEW BOLTON CTR, KENNETT SQ, PA 19348 USA
关键词
D O I
10.1046/j.1537-2995.1997.37197176951.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Human T-cell lymphoma/leukemia viruses types I and II (HTLV-I and HTLV-II) are related exogenous human retroviruses. The former is definitely pathogenic, while disease association with the latter is unclear There are two subtypes of HTLV-II, A and B. Currently, enzyme-linked immunosorbent assays (ELISAs) based on HTLV-I antigens are used to screen for the presence of HTLV-I and -II antibodies. Confirmation and subtyping are accomplished by Western blot (WE) or ELISAs based on HTLV-I whole viral antigens and/or HTLV-I and HTLV-IIA peptides. The sensitivity and specificity of these serologic assays were compared to those of HTLV-I- and -II-specific polymerase chain reaction (PCR) assays in tests on samples from Indians from South America in whom the HTLV-IIB subtype is endemic. STUDY DESIGN AND METHODS: Sera from 246 Gran Chaco Indians were evaluated for HTLV antibodies with the use of four ELISAs (Retrotek HTLV-I; Cambridge Biotech rgp21-enhanced HTLV-I/II; Vironostika HTLV-I/II; and Select HTLV-I/II), and a WE assay. Peripheral blood leukocyte DNA from each Indian was analyzed for HTLV-I or HTLV-II pol DNA via PCR. Fifteen of the PCR-positive samples were further subtyped via cloning and sequencing and/or oligomer restriction. RESULTS: Ninety-seven samples (39%) were positive for HTLV-II by serologic and/or PCR assays. All 15 positive DNA samples that were further analyzed were of the HTLV-IIB subtype and were clustered as a highly conserved phylogenetic group. Comparative analyses indicate that the sensitivity and specificity of the various assays were: PCR, 97 and 100 percent; Retrotek, 70 and 91 percent; Cambridge Biotech, 74 and 96 percent; Vironostika, 73 and 99 percent; Select, 72 and 98 percent; and WE, 70 and 100 percent. CONCLUSION: The sensitivities of the tested HTLV serologic assays were comparable. However, the specificity of the Retrotek ELISA was significantly lower than that of the others. When positive, the subtyping assays were very specific. However, PCR assays would seem preferable or to be a necessary adjunct for the sensitive detection of HTLV-IIB infection.
引用
收藏
页码:52 / 59
页数:8
相关论文
共 55 条
[1]  
ABBOTT LZ, 1994, J VIROL METHODS, V46, P51
[2]   ENZYMATIC GENE AMPLIFICATION - QUALITATIVE AND QUANTITATIVE METHODS FOR DETECTING PROVIRAL DNA AMPLIFIED INVITRO [J].
ABBOTT, MA ;
POIESZ, BJ ;
BYRNE, BC ;
KWOK, S ;
SNINSKY, JJ ;
EHRLICH, GD .
JOURNAL OF INFECTIOUS DISEASES, 1988, 158 (06) :1158-1169
[3]   HUMAN T-CELL LEUKEMIA-VIRUS (HTLV-I/II) SERODIAGNOSTIC TESTING - DISPARATE RESULTS AMONG A COHORT OF INTRAVENOUS-DRUG-USERS [J].
ABOULAFIA, DM ;
FEIGAL, E ;
VRANZIAN, K ;
BENNETT, C ;
BLATTNER, W ;
MOSS, A ;
SLAMON, D .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (10) :1043-1050
[4]  
ANDERSON DW, 1989, BLOOD, V74, P2585
[5]   DETECTION OF HUMAN T-CELL LYMPHOMA LEUKEMIA-VIRUS TYPE-I DNA AND ANTIGEN IN SPINAL-FLUID AND BLOOD OF PATIENTS WITH CHRONIC PROGRESSIVE MYELOPATHY [J].
BHAGAVATI, S ;
EHRLICH, G ;
KULA, RW ;
KWOK, S ;
SNINSKY, J ;
UDANI, V ;
POIESZ, BJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (18) :1141-1147
[6]   COMPARISON OF 6 COMMERCIAL HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) ENZYME-IMMUNOASSAY KITS FOR DETECTION OF ANTIBODY TO HTLV-I AND HTLV-II [J].
COSSEN, C ;
HAGENS, S ;
FUKUCHI, R ;
FORGHANI, B ;
GALLO, D ;
ASCHER, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (03) :724-725
[7]   GENETIC-HETEROGENEITY IN HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS TYPE-II [J].
DUBE, DK ;
SHERMAN, MP ;
SAKSENA, NK ;
BRYZGORNIA, V ;
MENDELSON, J ;
LOVE, J ;
ARNOLD, CB ;
SPICER, T ;
DUBE, S ;
GLASER, JB ;
WILLIAMS, AE ;
NISHIMURA, M ;
JACOBSEN, S ;
FERRER, JF ;
DELPINO, N ;
QUIRUELAS, S ;
POIESZ, BJ .
JOURNAL OF VIROLOGY, 1993, 67 (03) :1175-1184
[8]   SEROLOGICAL AND NUCLEIC-ACID ANALYSES FOR HIV AND HTLV INFECTION ON ARCHIVAL HUMAN PLASMA SAMPLES FROM ZAIRE [J].
DUBE, DK ;
DUBE, S ;
ERENSOY, S ;
JONES, B ;
BRYZGORNIA, V ;
SPICER, T ;
LOVE, J ;
SAKSENA, N ;
LECHAT, MF ;
SHRAGER, DI ;
DOSIK, H ;
GLASER, J ;
LEVIS, W ;
BLATTNER, W ;
MONTAGNA, R ;
BLUMBERG, BS ;
POIESZ, BJ .
VIROLOGY, 1994, 202 (01) :379-389
[9]   A RAPID AND SENSITIVE METHOD OF IDENTIFICATION OF HTLV-II SUBTYPES [J].
DUBE, S ;
SPICER, T ;
BRYZGORNIA, V ;
JONES, B ;
DEAN, T ;
LOVE, J ;
FERRER, J ;
ESTEBAN, N ;
HARRINGTON, W ;
GLASER, J ;
DUBE, DK ;
WILLIAMS, A ;
DOSIK, H ;
SIEGAL, F ;
POIESZ, BJ .
JOURNAL OF MEDICAL VIROLOGY, 1995, 45 (01) :1-9
[10]   MICROPLATE-BASED DNA HYBRIDIZATION ASSAYS FOR DETECTION OF HUMAN RETROVIRAL GENE-SEQUENCES [J].
DYSTER, LM ;
ABBOTT, L ;
BRYZGORNIA, V ;
POIESZ, BJ ;
PAPSIDERO, LD .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (02) :547-550